Published in Am J Physiol Lung Cell Mol Physiol on June 16, 2006
Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. J Clin Invest (2007) 1.50
Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest (2011) 1.16
Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1. Am J Pathol (2008) 1.11
Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice. J Mol Neurosci (2008) 1.02
Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain Behav Immun (2008) 1.02
Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 0.97
Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Eur Respir J (2010) 0.95
Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Exp Neurol (2008) 0.95
Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids (2011) 0.91
Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy. Ann Rheum Dis (2007) 0.88
Transcriptional and translational plasticity in rodent urinary bladder TRP channels with urinary bladder inflammation, bladder dysfunction, or postnatal maturation. J Mol Neurosci (2012) 0.87
VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses. PLoS One (2012) 0.87
VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension. Respir Res (2011) 0.85
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. Mol Vis (2011) 0.84
Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol Med (2008) 0.83
VIP gene deletion in mice causes cardiomyopathy associated with upregulation of heart failure genes. PLoS One (2013) 0.83
Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses. Clin Exp Immunol (2007) 0.83
Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. J Mol Neurosci (2008) 0.82
Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis. PLoS One (2014) 0.82
The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma. Peptides (2010) 0.82
Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages. J Cell Mol Med (2009) 0.82
Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior. Int J Dev Neurosci (2008) 0.81
Iraq dust is respirable, sharp, and metal-laden and induces lung inflammation with fibrosis in mice via IL-2 upregulation and depletion of regulatory T cells. J Occup Environ Med (2014) 0.81
Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders. Peptides (2007) 0.81
VIP Regulates the Development & Proliferation of Treg in vivo in spleen. Allergy Asthma Clin Immunol (2011) 0.81
Role of parasympathetic nerves and muscarinic receptors in allergy and asthma. Chem Immunol Allergy (2012) 0.81
Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs. Regul Pept (2010) 0.80
Vasoactive intestinal peptide signaling axis in human leukemia. World J Biol Chem (2011) 0.79
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review. Respir Res (2011) 0.79
Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase. BMC Immunol (2011) 0.79
Expression of phosphorylated cAMP response element binding protein (p-CREB) in bladder afferent pathways in VIP-/- mice with cyclophosphamide (CYP)-induced cystitis. J Mol Neurosci (2008) 0.78
Gene Deletion of VIP Leads to Increased Mortality Associated with Progressive Right Ventricular Hypertrophy. J Cardiovasc Dis (2014) 0.78
Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungs. PLoS One (2013) 0.76
Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases. Cytokine Growth Factor Rev (2017) 0.76
Cystic fibrosis transmembrane conductance regulator dysfunction in VIP knockout mice. Am J Physiol Cell Physiol (2014) 0.75
Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics. Hippokratia (2013) 0.75
Bronchoconstriction Induces Structural and Functional Airway Alterations in Non-sensitized Rats. Lung (2016) 0.75
Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am J Physiol Regul Integr Comp Physiol (2003) 3.37
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med (2008) 2.65
Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis. Lancet Oncol (2008) 2.63
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med (2013) 2.30
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int (2011) 2.28
Multistate analysis of factors associated with intimate partner violence. Am J Prev Med (2002) 2.22
Endemic nephropathy: the case for chronic poisoning by aristolochia. Croat Med J (2005) 2.03
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res (2008) 1.96
Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci U S A (2012) 1.82
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol (2012) 1.64
The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction. Ann Plast Surg (2010) 1.61
Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway. Hepatology (2013) 1.60
Amplitude and phase of cerebrospinal fluid pulsations: experimental studies and review of the literature. J Neurosurg (2006) 1.59
Respiratory symptoms necessitating spirometry among soldiers with Iraq/Afghanistan war lung injury. J Occup Environ Med (2011) 1.53
Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation (2007) 1.53
Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum (2004) 1.50
ADAMTS13 is expressed in hepatic stellate cells. Lab Invest (2005) 1.49
Arsenic in drinking water and stroke hospitalizations in Michigan. Stroke (2010) 1.49
Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem (2009) 1.48
A coupled level set framework for bladder wall segmentation with application to MR cystography. IEEE Trans Med Imaging (2010) 1.44
Rate and associations of epididymal cysts on pediatric scrotal ultrasound. J Urol (2010) 1.38
Removal of lead contaminated dusts from hard surfaces. Environ Sci Technol (2006) 1.38
A provider intervention to improve colorectal cancer screening in county health centers. Med Care (2008) 1.36
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer (2010) 1.31
Effectiveness of individually tailored calendars in promoting childhood immunization in urban public health centers. Am J Public Health (2004) 1.29
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Oncol (2008) 1.27
Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2009) 1.23
Environmental cadmium and breast cancer risk. Aging (Albany NY) (2010) 1.22
New-onset asthma among soldiers serving in Iraq and Afghanistan. Allergy Asthma Proc (2010) 1.22
Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. J Neurochem (2006) 1.21
An EM approach to MAP solution of segmenting tissue mixture percentages with application to CT-based virtual colonoscopy. Med Phys (2008) 1.19
Circadian rhythm in inhibitory synaptic transmission in the mouse suprachiasmatic nucleus. J Neurophysiol (2004) 1.18
Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression. Diabetes (2010) 1.16
Use of the All Patient Refined-Diagnosis Related Group (APR-DRG) Risk of Mortality Score as a Severity Adjustor in the Medical ICU. Clin Med Circ Respirat Pulm Med (2008) 1.15
Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma. PLoS One (2011) 1.13
Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J Neurosci (2002) 1.11
Lymphocyte regulation of neuropeptide gene expression after neuronal injury. J Neurosci Res (2003) 1.10
Comparison of potentially preventable hospitalizations related to diabetes among Native Hawaiian, Chinese, Filipino, and Japanese elderly compared with whites, Hawai'i, December 2006-December 2010. Prev Chronic Dis (2013) 1.06
Predictors of outcome following hip fracture rehabilitation. PM R (2010) 1.06
Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids. Neuroendocrinology (2008) 1.04
CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett (2004) 1.03
Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice. J Mol Neurosci (2008) 1.02
Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry. Chem Res Toxicol (2012) 1.00
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int J Cancer (2013) 1.00
Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice. Dev Biol (2007) 1.00
Antibody responses to vaccinia membrane proteins after smallpox vaccination. J Infect Dis (2007) 0.99
Reproducibility of diabetic macular edema estimates from SD-OCT is affected by the choice of image analysis algorithm. Invest Ophthalmol Vis Sci (2013) 0.99
The relationship between body iron stores and blood and urine cadmium concentrations in US never-smoking, non-pregnant women aged 20-49 years. Environ Res (2011) 0.99
Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 0.97
Effects of vasoactive intestinal peptide genotype on circadian gene expression in the suprachiasmatic nucleus and peripheral organs. J Biol Rhythms (2011) 0.97
The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus. Eur J Neurosci (2010) 0.97
Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse. Drug Metab Dispos (2010) 0.97
Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Exp Neurol (2008) 0.95
Negative regulation of Hedgehog signaling by liver X receptors. Mol Endocrinol (2009) 0.93
Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr Top Med Chem (2006) 0.92
STAT3-mediated astrogliosis protects myelin development in neonatal brain injury. Ann Neurol (2012) 0.91
Interaction of PACAP with Sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA. Cell Signal (2013) 0.91
Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. Int J Cancer (2008) 0.90
Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. BMC Cancer (2010) 0.90
Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry. Anal Chem (2013) 0.89
The accuracy of predicting cardiac arrest by emergency medical services dispatchers: the calling party effect. Acad Emerg Med (2003) 0.89
Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+ T-lymphocytes. Neuroreport (2004) 0.88
Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms. J Neurosci (2013) 0.88
Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant (2002) 0.88
VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses. PLoS One (2012) 0.87
Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice. Proc Natl Acad Sci U S A (2006) 0.87
Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawai'i. J Immigr Minor Health (2015) 0.87
Ionotropic glutamate receptors in lungs and airways: molecular basis for glutamate toxicity. Am J Respir Cell Mol Biol (2003) 0.87
Voiding dysfunction: outcome in infants with congenital vesicoureteral reflux. Urology (2005) 0.86
Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma. J Leukoc Biol (2013) 0.86
Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition. J Neurosci Res (2002) 0.86
Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth-muscle relaxation: analysis in neuronal nitric oxide synthase knockout mice. Chest (2003) 0.86
Growth factor-dependent actions of PACAP on oligodendrocyte progenitor proliferation. Regul Pept (2006) 0.85
The role of repeat victimization in adolescent delinquent behaviors and recidivism. J Adolesc Health (2003) 0.85
VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension. Respir Res (2011) 0.85
Vulnerability imposed by diet and brain trauma for anxiety-like phenotype: implications for post-traumatic stress disorders. PLoS One (2013) 0.85
Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice. Endocrinology (2012) 0.85
Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention. Am Heart J (2011) 0.84
Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis. ASN Neuro (2011) 0.84
New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody. Pulm Pharmacol Ther (2002) 0.84
Titanium and iron in lung of a soldier with nonspecific interstitial pneumonitis and bronchiolitis after returning from Iraq. J Occup Environ Med (2012) 0.84
Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat. ASN Neuro (2011) 0.83
Vasoactive intestinal peptide induction by ciliary neurotrophic factor in donor human corneal endothelium in situ. Neurosci Lett (2007) 0.83
VIP gene deletion in mice causes cardiomyopathy associated with upregulation of heart failure genes. PLoS One (2013) 0.83
Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis. J Endocrinol (2007) 0.83
Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis. J Mol Neurosci (2008) 0.82
Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis. Curr Pharm Des (2011) 0.82
Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE. PLoS One (2013) 0.81
Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice. J Mol Neurosci (2014) 0.81
17β-estradiol protects the lung against acute injury: possible mediation by vasoactive intestinal polypeptide. Endocrinology (2011) 0.81
VIP Regulates the Development & Proliferation of Treg in vivo in spleen. Allergy Asthma Clin Immunol (2011) 0.81
Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior. Int J Dev Neurosci (2008) 0.81